Covalon Showcases Contamination Protection Solution at ANCC Magnet & Pathway 2026 Conference Life Science Investing
Praxis Precision Medicines Announces Third Quarter 2026 Financial Results Date, Investor Day and November Conference Participation Life Science Investing
As Ebola Spreads to Multiple Countries, the Importance of NV-387 Oral Gummies Treatment Cannot be Understated - Phase II Clinical Trial Advancing Towards the Second Part, Says NanoViricides Life Science Investing
Firefly Neuroscience Strengthens Non-Invasive Brain-Computer Interface Growth Strategy with Commercially Available Versus Platform Life Science Investing
Beam Therapeutics Reports Initial Clinical Data from Phase 1/2 Trial of BEAM-301, Demonstrating Proof of Concept for Genetic Correction in Glycogen Storage Disease Type Ia at ESGCT 33rd Annual Congress Life Science Investing
Nautilus to Measure Proteoforms Driving Alzheimer's Disease and Cancer in ARPA-H-Funded SEEDS Consortium Life Science Investing
Cizzle Brands Accelerates U.S. National Exchange Listing Strategy to Drive Institutional Growth and Unlock Shareholder Value Biotech Investing
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 5, 2026 Life Science Investing
Medicenna Reports Potent CD122 Blockade and Extended Survival with MDNA209 in Preclinical Models of Autoimmune Disease Life Science Investing
Nuvectis Reports Positive Data from NXP200 Phase 1b Study Demonstrating Durable Responses, Including Complete Responses, in BRAF V600-mutated Recurrent or Progressive Gliomas Life Science Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
